Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease.
Journal: The Lancet. Rheumatology
Published: April 11, 2022
Low incidence and transient elevation of autoantibodies post mRNA COVID-19 vaccination in inflammatory arthritis.
Journal: Rheumatology (Oxford, England)
Published: January 28, 2022
Methotrexate Hampers Immunogenicity to BNT162b2 mRNA COVID-19 Vaccine in Immune-Mediated Inflammatory Disease.
Journal: medRxiv : the preprint server for health sciences
Published: May 20, 2021
Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease.
Journal: Annals of the rheumatic diseases
Published: April 20, 2021
Showing 1-4 of 4
Last Updated: 09/26/2026